LeMaitre Vascular, Inc. (LMAT) Q4 2016 Earnings Results

Lemaitre Vascular Misses on EPS, Stock Up 3.32%

Despite missing EPS expectations, Lemaitre Vascular's stock rose by 3.32%, likely driven by positive management commentary about long-term growth and product development. Investors may be encouraged by the company's focus on innovation, even in the face of a short-term earnings miss.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.13	N/A	-18.75%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about future opportunities. They emphasized their commitment to innovation and market expansion.

Management expressed confidence in the long-term growth potential of the company.

They highlighted ongoing investments in product development.

Lemaitre Vascular Misses on EPS, Stock Up 3.32%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular Misses on EPS, Stock Up 3.32%

Key numbers

Management commentary